MedPath

Clinical study on herbal neutraceuticals in stress management

Phase 2
Conditions
Health Condition 1: F411- Generalized anxiety disorder
Registration Number
CTRI/2022/09/045723
Lead Sponsor
MVR Ayurveda medical college and hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Both the sexes, which fulfills the diagnostic criteria

Exclusion Criteria

Hypertension, Cardiac disorders, IBD, Herb sensitivity, endocrine disorders, pregnancy and lactation etc

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood cortisoleTimepoint: before treatment, after 14 days; and followup on 28th day
Secondary Outcome Measures
NameTimeMethod
Hamilton Anxiety Rating scaleTimepoint: before treatment, after 14 days; and followup on 28th day
© Copyright 2025. All Rights Reserved by MedPath